Patents by Inventor Robert A. Galemmo, Jr.

Robert A. Galemmo, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4
    Patent number: 4920132
    Abstract: This invention relates to certain quinoline-diaryl compounds and their use as leukotriene D.sub.4 antagonists for the treatment of hypersensitive disorders.
    Type: Grant
    Filed: November 3, 1987
    Date of Patent: April 24, 1990
    Assignee: Rorer Pharmaceutical Corp.
    Inventors: Fu-chi Huang, Robert A. Galemmo, Jr., Henry F. Campbell
  • Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4
    Patent number: 4920133
    Abstract: This invention relates to certain quinoline-diaryl compounds and their use as leukotriene D.sub.4 antagonists for the treatment of hypersensitive disorders.
    Type: Grant
    Filed: November 3, 1987
    Date of Patent: April 24, 1990
    Assignee: Rorer Pharmaceutical Corp.
    Inventors: Fu-chi Huang, Robert A. Galemmo, Jr., Henry F. Campbell
  • Quinoline derivatives and use thereof as antagonists of leukotriene d4
    Patent number: 4918081
    Abstract: This invention relates to quinolinyl compounds of the general formula: ##STR1## and the use of these compounds as pharmacological agents which are lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties and their pharmaceutical compositions and processes for this preparation.
    Type: Grant
    Filed: June 20, 1988
    Date of Patent: April 17, 1990
    Assignee: Rorer Pharmaceutical Corp.
    Inventors: Fu-Chi Huang, Robert A. Galemmo, Jr., Henry F. Campbell
  • 3- and 5-(bicyclic ether or bicyclic alkylene thioether) alkylene amino thiatriazines
    Patent number: 4816583
    Abstract: A class of 3- and 5-amino thiatriazine compounds exhibiting pharmacological activity, including gastrointestinal anti-ulcerogenic and cytoprotective activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
    Type: Grant
    Filed: December 9, 1987
    Date of Patent: March 28, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Donald E. Kuhla, Henry F. Campbell, William L. Studt, Stuart A. Dodson, Robert A. Galemmo, Jr., Pamela J. Durham
  • 3- and 5-(bicyclic ether or bicyclic alkylene thioether) alkylene amino thiatriazines, and their pharmaceutical uses
    Patent number: 4727169
    Abstract: A class of 3- and 5-amino thiatriazine compounds exhibiting pharmacological activity, including gastrointestinal anti-ulcerogenic and cytoprotective activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
    Type: Grant
    Filed: February 4, 1987
    Date of Patent: February 23, 1988
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Donald E. Kuhla, Henry F. Campbell, William L. Studt, Stuart A. Dodson, Robert A. Galemmo, Jr., Pamela J. Durham